[1] |
YANG Sheng, WANG Deguo.
Effects of sakubatril valsartan combined with dagliflozin in the treatment of patients with HFrEF and the effect on serum cTnⅠ and BNP levels
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1010-1015.
|
[2] |
FAN Jianfeng,FANG Yi,ZHENG Chunhua.
Clinical efficacy of sacubitril valsartan in the treatment of chronic heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 810-814.
|
[3] |
GAO Yiwen, ZHANG Nan, LV Chanmei, YANG Xuanmei, YUE Guihua.
Effects of Huanglianjiedu Decoction on vascular endothelial NO pathway in young spontaneously hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 248-253.
|
[4] |
WEI Zihan,LI Dongbo,YUAN Zheng,LU Ying, YANG Guojie.
Clinical trial of sacubitril/valsartan in the treatment of Pulmonary hypertension (PH) due to left heart disease (LHD)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(1): 57-62.
|
[5] |
HU Kunmei, HU Haoran, SHEN Yuanyuan, LU Yining, YANG Jieren, HAN Jun.
Effect of traditional Chinese medicine Yuxia capsule on renal fibrosis in spontaneously hypertensive rats and its relationship with TGF-β1/Smads signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 387-393.
|
[6] |
ZHAO Yanyun, WU Xiaoyan, WANG Guomin, FENG Yulin, DONG Feixia.
Experimental study of benazepril intervene Wnt signaling inhibits renal fibrosis in UUO rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1332-1339.
|
[7] |
XUE Wan-wan, HONG Hua-shan, LIN Xiao-hong, LIN Jun-hua, FANG Mei-qin.
Expression of TRPC in the smooth muscle cells of the small intramyocardial arteries in the left ventricles of spontaneously hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 879-884.
|
[8] |
LIU Yan, YANG Jie-ren, HAO Wei, ZHANG Jun-xiu, TANG Li-juan, CHEN Guo-xiang.
Mechanisms and protective effect of compound Shanju on aortal injury in spontaneously hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(7): 732-737.
|
[9] |
YANG Yan-lang1,2, ZOU He-qun1, ZHANG Dao-you2, WANG Yu-wei2, LI Fan-xia2, GAO Chao-qing2, XU Hai-hong2, CHENG Xiao-mei2.
Renal tubular protection effect of combining benazepril and spironolactone in adriamycin-induced nephritic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(4): 381-386.
|
[10] |
CHEN Hua, YING Wei-xing, LI Rong-zhou.
Combined treatment of vitamin K2 and benazepril induces apoptosis and inhibits angiogenesis on gastric cancer in vitro experiments
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(6): 621-626.
|
[11] |
WANG Yan, ZHANG Ming-sheng, LIU Yu, CHEN Min.
Effect of nebivolol on circle and aortic renin-angiotensin system in spontaneously hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(7): 770-774.
|
[12] |
LI Ling, TAN Zhi-rong, CHEN Yao, ZHOU Gan, GUO Dong, YAN Jin, YANG Guo-ping, OUYANG Dong-sheng.
A rapid and sensitive LC-MS/MS method for determination of valsartan in human plasma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(7): 809-813.
|
[13] |
WU Xiao-dong, ZHANG Dao-you, CUI Ming-chun, YANG Li-cai, YANG Yan-lang, ZHU Xin-jian.
Influence of valsartan and fluvastatin on hepatocyte growth factor in adriamycin-induced nephrotic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(3): 305-309.
|
[14] |
WANG Xin, YANG Yu-wen, WANG An-cai, KONG Xiang-quan.
Effects of valsartan on BKCa of hypoxic pulmonary hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(9): 1032-1035.
|
[15] |
YANG Yan-lang, ZHANG Dao-you, WANG Xiang-ming, CUI Ming-chun, WU Xiao-dong.
Renoprotective effect and mechanisms of benazepril and pentifylline on adriamycin nephropathy rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(7): 736-740.
|